(19)
(11) EP 1 129 175 A2

(12)

(88) Date of publication A3:
27.07.2000

(43) Date of publication:
05.09.2001 Bulletin 2001/36

(21) Application number: 99950725.4

(22) Date of filing: 14.10.1999
(51) International Patent Classification (IPC)7C12N 5/00
(86) International application number:
PCT/EP9907/741
(87) International publication number:
WO 0023/567 (27.04.2000 Gazette 2000/17)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 16.10.1998 US 173633
04.05.1999 US 132476 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE CY 
  • Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
    1235 Wien (AT)

    AT 

(72) Inventors:
  • LAVAU, Catherine, P.
    Palo Alto, CA 94306 (US)
  • YOUNG, Judy, Carol
    San Carlos, CA 94070 (US)
  • HILL, Beth, Louise
    Sunnyvale, CA 94087 (US)

(74) Representative: Becker, Konrad 
Novartis AGCorporate Intellectual PropertyPatent- und Markenabteilung
4002 Basel
4002 Basel (CH)

   


(54) PROMOTION OF SELF-RENEWAL AND IMPROVED GENE TRANSDUCTION OF HEMATOPOIETIC STEM CELLS BY HISTONE DEACETYLASE INHIBITORS